CNTOF
ABBV icon

Canandaigua National Trust of Florida’s AbbVie ABBV Stock Holding History

Canandaigua National Trust of Florida’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$317K Buy
1,458
+95
+7% +$21.1K 0.25% 89
2025
Q4 		$311K Sell
1,363
-3
-0.2% -$683 0.19% 102
2025
Q3 		$316K Sell
1,366
-23
-2% -$4.68K 0.25% 86
2025
Q2 		$258K Sell
1,389
-114
-8% -$21.2K 0.18% 109
2025
Q1 		$315K Sell
1,503
-121
-7% -$23.5K 0.28% 85
2024
Q4 		$289K Hold
1,624
– – 0.23% 98
2024
Q3 		$321K Buy
+1,624
New +$303K 0.28% 84

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Canandaigua National Trust of Florida's ABBV Position: Q1 2026 in Review

Canandaigua National Trust of Florida increased its AbbVie (ABBV) stake by 7% in Q1 2026, buying an estimated $21.1K and bringing the position to 1,458 shares worth $317K. The position accounts for 0.25% of the portfolio, ranked #89.

Canandaigua National Trust of Florida first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. The position peaked at $321K in Q3 2024. 4,103 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Canandaigua National Trust of Florida held 1,458 shares of AbbVie worth $317K as of Q1 2026.
  • Canandaigua National Trust of Florida bought 95 AbbVie shares in Q1 2026, an estimated $21.1K.
  • AbbVie made up 0.25% of Canandaigua National Trust of Florida's portfolio in Q1 2026, its #89 holding.
  • Canandaigua National Trust of Florida first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
  • Canandaigua National Trust of Florida's AbbVie position peaked at $321K in Q3 2024.
  • 4,103 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Canandaigua National Trust of Florida's 13F filing for Q1 2026, filed 8 Apr 2026.